Dannielle Appelhans - Net Worth and Insider Trading
Dannielle Appelhans Net Worth
The estimated net worth of Dannielle Appelhans is at least $22,200 dollars as of 2024-12-26. Dannielle Appelhans is the Director of Generation Bio Co and owns about 20,000 shares of Generation Bio Co (GBIO) stock worth over $22,200. Dannielle Appelhans is also the CEO and President of Rubius Therapeutics Inc and owns about 0 shares of Rubius Therapeutics Inc (RUBY) stock worth over $0. Details can be seen in Dannielle Appelhans's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dannielle Appelhans has not made any transactions after 2023-12-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dannielle Appelhans
Dannielle Appelhans Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dannielle Appelhans owns 2 companies in total, including Rubius Therapeutics Inc (RUBY) , and Generation Bio Co (GBIO) .
Click here to see the complete history of Dannielle Appelhans’s form 4 insider trades.
Insider Ownership Summary of Dannielle Appelhans
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RUBY | Rubius Therapeutics Inc | 2023-02-24 | CEO and President |
| GBIO | Generation Bio Co | 2023-12-08 | director |
Dannielle Appelhans Latest Holdings Summary
Dannielle Appelhans currently owns a total of 2 stocks. Among these stocks, Dannielle Appelhans owns 20,000 shares of Generation Bio Co (GBIO) as of December 8, 2023, with a value of $22,200 and a weighting of 100%. Dannielle Appelhans also owns 0 shares of Rubius Therapeutics Inc (RUBY) as of February 24, 2023, with a value of $0 and a weighting of 0%.
Latest Holdings of Dannielle Appelhans
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GBIO | Generation Bio Co | 2023-12-08 | 20,000 | 1.11 | 22,200 |
| RUBY | Rubius Therapeutics Inc | 2023-02-24 | 0 | 0.06 | 0 |
Holding Weightings of Dannielle Appelhans
Dannielle Appelhans Form 4 Trading Tracker
According to the SEC Form 4 filings, Dannielle Appelhans has made a total of 2 transactions in Generation Bio Co (GBIO) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Generation Bio Co is the acquisition of 8,000 shares on December 8, 2023, which cost Dannielle Appelhans around $14,320.
According to the SEC Form 4 filings, Dannielle Appelhans has made a total of 3 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Rubius Therapeutics Inc is the sale of 10,385 shares on February 24, 2023, which brought Dannielle Appelhans around $1,350.
Insider Trading History of Dannielle Appelhans
- 1
Dannielle Appelhans Trading Performance
GuruFocus tracks the stock performance after each of Dannielle Appelhans's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dannielle Appelhans is 94.02%. GuruFocus also compares Dannielle Appelhans's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dannielle Appelhans within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dannielle Appelhans's insider trading performs compared to the benchmark.
Performance of Dannielle Appelhans
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.23 | | | | | |
| Relative Return to S&P 500(%) | 17.2 | | | | | |
Dannielle Appelhans Ownership Network
Dannielle Appelhans Owned Company Details
What does Rubius Therapeutics Inc do?
Who are the key executives at Rubius Therapeutics Inc?
Dannielle Appelhans is the CEO and President of Rubius Therapeutics Inc. Other key executives at Rubius Therapeutics Inc include director & Chief Executive Officer Pablo J Cagnoni , Chief Scientific Officer Laurence A. Turka , and CLO & Corp. Secretary Maiken Keson-brookes .
Rubius Therapeutics Inc (RUBY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Rubius Therapeutics Inc (RUBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rubius Therapeutics Inc (RUBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Rubius Therapeutics Inc (RUBY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rubius Therapeutics Inc Insider Transactions
Dannielle Appelhans Mailing Address
Above is the net worth, insider trading, and ownership report for Dannielle Appelhans. You might contact Dannielle Appelhans via mailing address: C/o Rubius Therapeutics, Inc., 399 Binney Street, Suite 300, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
